Now available, Taro-Fingolimod, a generic alternative to Gilenya®
Given the unique requirements of Fingolimod, Taro will be launching the TaroCares® Program to support our product and minimize any disruption to Patients, Physicians, or Pharmacists.
To enroll a patient for support or to schedule first-dose observation please call 1.833.618.0571
Release Date:
Lundi, novembre 4, 2019